Yet, they imply possible new avenues of investigation in humans, namely to examine the role of intracellular calcium homeostasis as an arrhythmia trigger and as a therapeutic target in patients with mutations in PKP2, even in the absence of overt structural disease. This evidence concerns the gene PKP2 and Arrhythmia.